{"id":"https://genegraph.clinicalgenome.org/r/9b79e204-45af-4935-91a2-ce39a0586dcbv1.0","type":"EvidenceStrengthAssertion","dc:description":"*PHKA1was* first reported in relation to X-linked recessive Glycogen storage disease type IX d (GSD IXd) in 1994 (Wehner et al., PMID: 7874115). GSD IXd (OMIM:311870) is caused by a defect in the PHKA1 gene, which encodes the alpha subunit of phosphorylase kinase (PhK) in muscle. A defect in this subunit leads to reduced PhK enzyme activity. This enzyme deficiency impairs the breakdown of glycogen, resulting in its accumulation in muscle cells. Symptoms of GSD IXd commonly include muscle weakness, exercise intolerance, cramps, and, in some cases, progressive myopathy.\n\nAt least 14 variants (e.g. missense, nonsense, and frameshift) have been reported in humans. Clinical evidence supporting this gene-disease relationship includes case-level data. Variants in this gene have been reported in at least 15 probands in 14 publications (PMID: 7874115, 12825073, 15637709, 22238410, 18401027, 34615823, 9731190, 35957617, 32303402, 28600779, 20080404, 35710611, 33799212, 38586167). There is no more prevalent in any ethnic group with PHKA1 gene mutation\n\nThis gene-disease relationship is also supported by experimental evidence, including animal models, expression studies, biochemical function analysis. (PMID: 6020474, 8298647, 13402896, 25613900, 32707033, 33961781, 38548794, 1409665). The I strain of mice is characterized by significantly higher muscle glycogen levels compared to other strains. Studies have shown that these mice maintain elevated muscle glycogen concentrations in both fed and fasted states, regardless of dietary fat content. Notably, the I strain exhibits a deficiency in phosphorylase kinase (PhK) activity. A cross-mating study between I-strain and C57-strain mice demonstrated that the inheritance pattern is X-linked. This PhK deficiency in I-strain mice is caused by frameshift mutations in the PHKA1 gene, which encodes the alpha subunit of PhK. Protein interaction studies suggest that the alpha subunit may bind to calmodulin and the delta subunit of PhK, and also interacts with the beta and gamma subunits, contributing to the enzyme's regulatory functions. Farnesylation of the alpha subunit of phosphorylase kinase is critical for maintaining the enzyme's structural integrity.\n\nIn summary, there is definitive evidence supporting the relationship between *PHKA1* and X-linked recessive Glycogen storage disease type IX d. This has been repeatedly demonstrated in both the research and clinical diagnostic settings. This classification was approved by the ClinGen General Inborn Errors of Metabolism GCEP on the meeting date [January 10, 2025] (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9b79e204-45af-4935-91a2-ce39a0586dcb","GCISnapshot":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10097","date":"2025-01-10T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10097","date":"2025-05-22T15:17:03.641Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbb54681-389f-41fb-b76f-3eaab7c73419","type":"EvidenceLine","dc:description":"Score downgraded due to genetic studies only, sharing the default score with other studies involving I-strain mice","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be32665a-ad3e-4ce6-b5e7-d81ce4b0cad1","type":"Finding","dc:description":"In the I-strain mouse, \n- Phk-alpha m activity is practically abolished in skeletal muscle and partially reduced in heart and brain but normal in the liver\n-Increased muscle glycogen content\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298647","rdfs:label":"Schneider 1993","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c3b1b06e-0b2d-42e5-8e41-0f61f17e17de","type":"EvidenceLine","dc:description":"Score downgraded due to reliance on enzyme studies only, sharing the default score with other studies involving I-strain mice","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64819de9-1bff-4540-8d9b-32aa6f744234","type":"Finding","dc:description":"Enzyme activity and glycogen storage \n X-linked inheritance","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6020474","rdfs:label":"Lyon 1967","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/df4f0a98-a4a1-4bbf-9ea2-89610b05a0f8","type":"EvidenceLine","dc:description":"This paper focused on the study of glycogen in muscle in I-strain mice, sharing the default score with other studies involving I-strain mice.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ce7f8a0-c436-4d84-bcee-ed62160e0b7a","type":"Finding","dc:description":"increased glycogen content in the muscle tissue and not in liver","dc:source":"https://pubmed.ncbi.nlm.nih.gov/13402896","rdfs:label":"Lyon 1956","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4142918e-a754-4c48-8479-4044cf4993cf","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bf68bcb-44db-4948-956a-51dc62545f98","type":"Finding","dc:description":"Lack of farnesylation will reduce the activity of the PHK enzyme by impairing its membrane association ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1409665","rdfs:label":"Heilmeyer 1992","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/15128ec6-0c69-40d3-984c-1bb90cf12a7f","type":"EvidenceLine","dc:description":"Extra evidence for farnesylcysteine and found exact site of farnesylation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbc9e590-add6-4102-b17d-33a29b00787a","type":"Finding","dc:description":"The lack of farnesylation will reduce PHK enzyme activity by impairing its membrane association","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38548794","rdfs:label":"Wang 2024","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/444b7019-70ca-409c-9ba7-0569d124c198","type":"EvidenceLine","dc:description":"Another study demonstrates similar interactions","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f74aac6a-20b6-48e0-9733-048de57484ae","type":"Finding","dc:description":"PHKG2 encodes the gamma subunit, while PHKA1 encodes the alpha subunit of the phosphorylase b kinase enzyme.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707033","rdfs:label":"Buljan 2020","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/54b74228-bfae-4423-9dd7-812758ba5597","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e20ebf6-8a13-429e-a05d-4426461b21b2","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33961781","rdfs:label":"Huttlin 2021","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c8a70664-ef9a-4636-afeb-f406931de28f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e95d80f3-ada7-4f49-bb13-32f24a5e4cd4","type":"Finding","dc:description":"PHKA1 is predominantly expressed in skeletal muscle","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"UhlÃ©n et al 2015","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/acc3fc43-7f42-481e-957a-b10fd10df3d5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3380f90f-622f-40d5-9439-b651a31f5926","type":"EvidenceLine","dc:description":"due to nonsense mediated decay, exon 31 of 32\npresent in four hemizygotes in gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3380f90f-622f-40d5-9439-b651a31f5926_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7874115","allele":{"id":"https://genegraph.clinicalgenome.org/r/3782541c-dda3-49cc-afeb-9a6f2822d608","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.3334G>T (p.Glu1112Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120813"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/484620e8-fa22-4eda-aeef-2bf3d24def9a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/484620e8-fa22-4eda-aeef-2bf3d24def9a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"expression","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/484620e8-fa22-4eda-aeef-2bf3d24def9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12825073","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7fc36e0-3596-4560-863a-3be6f6727130","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.896A>T (p.Asp299Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120815"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/96eecdf6-6457-4436-a759-a568be2125c2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96eecdf6-6457-4436-a759-a568be2125c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18401027","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a40e5ea-6fbb-4827-a88f-9d935d39689a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.667G>A (p.Gly223Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120816"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ff3a1f28-3413-463e-90fe-a087017a17e0","type":"EvidenceLine","dc:description":"This deletion mutation causes a frameshift leading eventually to a premature stop codon at amino acid position 242) - exon 7 of the PHKA1 gene\npresent in 1 hemizygotes in gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff3a1f28-3413-463e-90fe-a087017a17e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15637709","allele":{"id":"https://genegraph.clinicalgenome.org/r/3fa9cd91-9795-4e56-9fcc-de060c15b788","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.695del (p.Ala232ValfsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184774"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/08f666ec-31f3-4b47-a832-800e9573f859","type":"EvidenceLine","dc:description":"nonsense variant (in exon 12), downgrade it from the 1.5 default due to lack of phenotypic information to confirm specificity of diagnosis. \n\ntwo hemizygotes in gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08f666ec-31f3-4b47-a832-800e9573f859_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28600779","allele":{"id":"https://genegraph.clinicalgenome.org/r/c00ecb62-808b-40f3-9121-a094937febda","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.1174C>T (p.Arg392Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413593161"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/58a0b233-cfaa-4cdd-b7a3-4b02d249c91e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58a0b233-cfaa-4cdd-b7a3-4b02d249c91e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35710611","allele":{"id":"https://genegraph.clinicalgenome.org/r/1701b468-b5a2-4b01-b93e-800b1b4d4da1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.915A>T (p.Lys305Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413593793"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/911f1509-65f6-4c38-887d-77c76d371d8b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/911f1509-65f6-4c38-887d-77c76d371d8b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32303402","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8f178ca-7336-4748-8f89-c07dc2e06f8d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.586G>A (p.Glu196Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413594711"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7816ca7e-b8b3-4921-8468-b9088de41aed","type":"EvidenceLine","dc:description":"This variant is a frameshift variant that causes the encoded protein to terminate prematurely in exon 19 (32 exons in total), which may result in loss of coding protein function. \n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7816ca7e-b8b3-4921-8468-b9088de41aed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35957617","allele":{"id":"https://genegraph.clinicalgenome.org/r/8626506f-b050-4fdd-b05c-08d869bff20a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.1989_1990delinsAAGTTGCTCGTGATCTAAA (p.Tyr663Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695234626"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e3d59fe5-5eea-4561-b1d6-33d4132b6e72","type":"EvidenceLine","dc:description":"PHKA1 gene, c.1360A > G p.Ile454Val (exon 14) inherited by his mother","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3d59fe5-5eea-4561-b1d6-33d4132b6e72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38586167","allele":{"id":"https://genegraph.clinicalgenome.org/r/43146182-239c-406b-acc9-8f59b8459810","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.1360A>G (p.Ile454Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10450876"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/740f72e7-9338-4372-ba86-de445b582a33","type":"EvidenceLine","dc:description":"This deletion in exon 23 introduces a frameshift at amino acid 865 leading to a predicted premature stop codon 15 amino acids downstream p.(Lys865Argfs*15) ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/740f72e7-9338-4372-ba86-de445b582a33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33799212","allele":{"id":"https://genegraph.clinicalgenome.org/r/92d74734-5823-48a6-b80e-dfef36e611ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.2594del (p.Lys865ArgfsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695234757"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a309e564-bc2b-42ce-9e42-c0236cda633d","type":"EvidenceLine","dc:description":"identified a single nucleotide insertion that created a premature stop codon (c.3579_3580insT, p.S1194*) in exon 32 in PHKA1\n\nDowngrade due exon 32 is the last exon so this isn't expected to cause NMD and the decrease in enzyme activity was relatively mild so this likely is not a true null variant (there is at least some, partially, functional protein being made)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a309e564-bc2b-42ce-9e42-c0236cda633d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34615823","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec4377d0-141f-4c82-8cd5-d1d579c2dc22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.3579_3580insT (p.Ser1194Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695236095"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/da9180f7-39c6-4b8c-9f42-4b267097c3f2","type":"EvidenceLine","dc:description":"creating premature stop codons in the PHKA1 gene (del1293T, p.F430fsX445) ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da9180f7-39c6-4b8c-9f42-4b267097c3f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22238410","allele":{"id":"https://genegraph.clinicalgenome.org/r/b018d716-a6e7-476e-b925-317eec188831","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.1293del (p.Thr432LeufsTer14)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695234628"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e1ed465b-6443-476b-8584-fc8123125c72","type":"EvidenceLine","dc:description":"Direct sequencing of the 32 exons of the PHKA1 gene showed a novel del1394T mutation in exon 14, which introduces a frameshift and causes a premature stop codon at amino acid position 486 (T464fsX486); \nNumber of hemizygotes: 1","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1ed465b-6443-476b-8584-fc8123125c72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20080404","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b43044f-f8b2-41f8-9b23-a41091eeb712","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.1395del (p.Ile465MetfsTer22)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2579646129"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a1e95bb3-a777-45bf-a2ab-c08bc2192600","type":"EvidenceLine","dc:description":"Splice-site mutations: a G-to-C transversion at the 5-prime end of an intron (referred to as 'intron L' by them). The mutation destroys the highly conserved GT sequence at the 5-prime splice junction of the intron, which resulted in skipping of the preceding 201-bp exon. \n\ndown grade: because it is the penultimate exon that is skipped so it is not predicted to cause NMD so it is not clear that the variant has a null effect, furthermore the authors were not able to determine the level of mutant mRNA","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1e95bb3-a777-45bf-a2ab-c08bc2192600_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9731190","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ee762d3-012e-45c3-99d9-d8c8cb239d02","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002637.4(PHKA1):c.3498+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413580813"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":10459,"specifiedBy":"GeneValidityCriteria11","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/_tLz8PcLe7Y","type":"GeneValidityProposition","disease":"obo:MONDO_0010362","gene":"hgnc:8925","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_acc3fc43-7f42-481e-957a-b10fd10df3d5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}